PPM1D silencing by lentiviral-mediated RNA interference inhibits proliferation and invasion of human glioma cells

Abstract

To construct a lentiviral shRNA vector targeting human protein phosphatase 1D magnesium-dependent (PPM1D) gene and detect its effectiveness of gene silencing in human gliomas, specific siRNA targets with short hairpin frame were designed and synthesized. DNA oligo was cloned into the pFU-GW-iRNA lentiviral expression vector, and then PCR and sequencing analyses were conducted to verify the constructs. After the verified plasmids were transfected into 293T cells, the lentivirus was produced and the titer of virus was determined. Real-time quantitative PCR and Western blot were performed to detect the PPM1D expression level in the infected glioma cells. PCR and Western blot analyses revealed the optimal interfering target, and the virus with a titer of 6×10⁸ TU/mL was successfully packaged. The PPM1D expression in human glioma cells was knocked down at both mRNA and protein levels by virus infection. The expression of PPM1D mRNA and protein was decreased by 76.3% and 87.0% respectively as compared with control group. The multiple functions of human glioma cells after PPM1D RNA interference were detected by flow cytometry and cell counting kit-8 (CCK-8). Efficient down-regulation of PPM1D resulted in significantly increased cell apoptosis and reduced cell proliferation and invasion potential in U87-MG cells. We have successfully constructed the lentiviral shRNA expression vector capable of stable PPM1D gene silencing at both mRNA and protein levels in glioma cells. And our data gave evidence that the reduced cell growth observed after PPM1D silencing in glioma cells was at least partly due to increased apoptotic cell death.

Keywords

PPM1D / glioma / RNA interference / lentivirus / apoptosis

References

[1] DehdashtiA.R., HegiM.E., RegliL., et al.. New trends in the medical management of glioblastoma multiforme: the role of temozolomide chemotherapy. Neurosurg Focus, 2006, 20(4): E6

[2] SchwartzbaumJ.A., FisherJ.L., AldapeK.D., et al.. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol, 2006, 2(9): 494-503

[3] FiscellaM., ZhangH., FanS., et al.. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci USA, 1997, 94(12): 6048-6053

[4] ChoiJ., AppellaE., DonehowerL.A.. The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene. Genomics, 2000, 64(3): 298-306

[5] LiJ., YangY., PengY., et al.. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat Genet, 2002, 31(2): 133-134

[6] GorgoulisV.G., VassiliouL.V., KarakaidosP., et al.. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature, 2005, 434(7035): 907-913

[7] BulavinD.V., DemidovO.N., SaitoS., et al.. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet, 2002, 31(2): 210-215

[8] TaylorW.R., StarkG.R.. Regulation of the G2/M transition by p53. Oncogene, 2001, 20(15): 1803-1815

[9] Saito-OharaF., ImotoI., InoueJ., et al.. PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res, 2003, 63(8): 1876-1883

[10] HirasawaA., Saito-OharaF., InoueJ., et al.. Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. Clin Cancer Res, 2003, 9(6): 1995-2004

[11] CastellinoR.C., De BortoliM., LuX., et al.. Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D. J Neurooncol, 2008, 86(3): 245-256

[12] LuX., MaO., NguyenT.A., et al.. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. Cancer Cell, 2007, 12(4): 342-354

[13] LuX., NguyenT.A., ZhangX., et al.. The Wip1 phosphatase and Mdm2: cracking the “Wip” on p53 stability. Cell Cycle, 2008, 7(2): 164-168

[14] RodriguezM., AladowiczE., LanfranconeL., et al.. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. Cancer Res, 2008, 68(19): 7872-7881

[15] LuX., NguyenT.A., MoonS.H., et al.. The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways. Cancer Metastasis Rev, 2008, 27(2): 123-135

[16] ChoiJ., NannengaB., DemidovO.N., et al.. Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control. Mol Cell Biol, 2002, 22(4): 1094-1105

[17] GartelA.L., KandelE.S.. RNA interference in cancer. Biomol Eng, 2006, 23(1): 17-34

[18] WangX., TangR., XueZ., et al.. Lentivector-mediated RNAi efficiently downregulates expression of murine TNF-alpha gene in vitro and in vivo. J Huazhong Univ Sci Technolog [Med Sci], 2009, 29(1): 112-117

[19] CenciarelliC., BudoniM., MercantiD., et al.. In vitro analysis of mouse neural stem cells genetically modified to stably express human NGF by a novel multigenic viral expression system. Neurol Res, 2006, 28(5): 505-512

[20] MeunierA., LatremoliereA., DominguezE., et al.. Lentiviral-mediated targeted NF-kappaB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat. Mol Ther, 2007, 15(4): 687-697

[21] ParssinenJ., AlarmoE.L., KhanS., et al.. Identification of differentially expressed genes after PPM1D silencing in breast cancer. Cancer Lett, 2008, 259(1): 61-70

[22] MacurekL., LindqvistA., VoetsO., et al.. Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition. Oncogene, 2010, 29(15): 2281-2291

[23] ZhangX., LinL., GuoH., et al.. Phosphorylation and degradation of MdmX is inhibited by Wip1 phosphatase in the DNA damage response. Cancer Res, 2009, 69(20): 7960-7968

[24] LoukopoulosP., ShibataT., KatohH., et al.. Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome. Cancer Sci, 2007, 98(3): 392-400

[25] DemidovO.N., KekC., ShreeramS., et al.. The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis. Oncogene, 2007, 26(17): 2502-2506